Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1997
11/20/1997WO1997042967A1 Antithrombotic materials and methods
11/20/1997WO1997042956A1 Didhydropyrimidines and uses thereof
11/20/1997WO1997042941A2 Buccal delivery system
11/20/1997WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997WO1997030677A3 Pentafluorobenzenesulfonamides and analogs
11/20/1997DE19619614A1 New sulphonamide derivatives of chroman
11/20/1997CA2253876A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997CA2253862A1 Dihydropyrimidines and uses thereof
11/20/1997CA2253836A1 Antithrombotic materials and methods
11/20/1997CA2253566A1 Arylalkylpiperazine compounds as antioxidants
11/19/1997EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7
11/19/1997EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997EP0807633A2 Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
11/19/1997EP0807632A1 Pyrroloazepine derivatives
11/19/1997EP0807629A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them
11/19/1997EP0807628A1 Aromatic compound and pharmaceutical composition
11/19/1997EP0807627A2 Anilide compounds as ACAT inhibitors
11/19/1997EP0807437A1 Polyacrylilic and polymethacrylic acid containing compositions with antiadhesion properties
11/19/1997EP0807122A1 Novel receptor
11/19/1997EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997EP0807109A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht 1d? receptor agonists
11/19/1997EP0806965A1 Cd44 expression in smooth muscle cells
11/19/1997EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997EP0806958A1 Inhibition of platelet binding
11/19/1997EP0598093B1 Quinuclidine derivatives as squalene synthetase inhibitors
11/19/1997EP0566567B1 Antihypertensive benzopyran derivatives
11/19/1997CN1165146A Process for purifying Tamm-Horsfall glycoprotein or uromodulin, their purified products and method for making discrimination between both of them
11/19/1997CN1165025A Chinese drugs for treatment of coronary heart disease
11/19/1997CN1165000A Method of reducing tissue damage associated with ischemia
11/19/1997CN1164999A Benzopyran derivative and use of said benzopyran derivative for treating heart disease
11/18/1997US5688990 Forming chemical intermediates for azetidinone compounds that inhibit cholesterol biosynthesis for prevention of atherosclerosis
11/18/1997US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1997US5688956 Method for preparing N-methyl 2-(3-pyridyl) (1R,2R)-2-tetrahydrothiopyrancarbothioamide-1-oxide
11/18/1997US5688954 Process for the preparation of substituted thiopyran-1-oxides
11/18/1997US5688952 Vasoconstrictor intermediates
11/18/1997US5688946 Amino acid derivatives having renin inhibiting activity
11/18/1997US5688945 Compounds
11/18/1997US5688938 Calcium receptor-active molecules
11/18/1997US5688803 Tricyclic dicarbonyl derivatives
11/18/1997US5688802 Treatment of alzheimer's disease, organic brain syndrome, parkinson's disease, senile dementia
11/18/1997US5688793 Pyridazino 4',5':3,4!pyrrolo- 2,1-a!-isoquinolines and the use thereof for preparing pharmaceutical preparations
11/18/1997US5688780 Anticholesterol agents, cholesterol biosynthesis inhibition
11/18/1997US5688768 Recombinant thrombin receptor and related pharmaceuticals
11/18/1997US5688507 Cardiovascular disorders such as treatment of angina, heart attack, stroke and as anticoagulants
11/18/1997US5688499 Antagonism of endothelin actions
11/18/1997CA2122360C Quinazolinone antianginal agents
11/15/1997CA2205477A1 Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/13/1997WO1997042337A1 Gene expression in monocytes and macrophages
11/13/1997WO1997042187A1 Oxindole derivatives
11/13/1997WO1997041881A1 Morphogen treatment for chronic renal failure
11/13/1997WO1997041880A1 Therapies for chronic renal failure
11/13/1997WO1997041857A1 Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock
11/13/1997WO1997041851A1 Benzothiophenes, formulations containing same, and methods
11/13/1997WO1997041847A1 Antioxidant compounds
11/13/1997WO1997033996A3 Human bikunin
11/13/1997WO1997027177A3 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists
11/13/1997WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997CA2253858A1 Benzothiophenes, formulations containing same, and methods
11/13/1997CA2253322A1 Gene expression in monocytes and macrophages
11/13/1997CA2251969A1 Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock
11/13/1997CA2205121A1 Antiadhesive properties of polyacrylic acids and polymethacrylic acids
11/12/1997EP0806423A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
11/12/1997EP0806420A1 Benzothiophenes, formulations containing same, and methods
11/12/1997EP0806140A1 Taxol composition for use as organ preservation and cardioplegic agents
11/12/1997EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
11/12/1997EP0805858A2 Inhibition of neovascularization using vegf-specific oligonucleotides
11/12/1997EP0805818A1 Novel peptides, their production and use
11/12/1997EP0805817A1 Thiol derivatives with metallopeptidase inhibitory activity
11/12/1997EP0805802A1 Substituted phenyl compounds as endothelin antagonists
11/12/1997EP0805678A1 Surface-modified nanoparticles and method of making and using same
11/12/1997EP0605622B1 Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
11/12/1997CN1164856A Novel alkylamino derivatives as sigma 2 selective ligands
11/12/1997CN1164573A Method for extracting SOD from earthworm and SOD series health-care food
11/12/1997CN1036396C Process for preparing (E)-3-£2-n-butyl-1-{(4-carboxyl-phenyl)methyl}-1H-imidazol-5-yl}-2-(2-thienyl) methyl-2-acrylic methylsulfonate
11/12/1997CN1036394C Method for preparation of carbostyril derivatives
11/12/1997CN1036393C 7-(2-aminoethyl)-benzothiazolones
11/12/1997CN1036392C Method for preparation of ring-substituted 2-amino-tetralin and 3-aminochromanes
11/11/1997US5686628 Proline derivatives
11/11/1997US5686615 Stereoselective preparation of substituted piperidines
11/11/1997US5686609 Aromatic amine compounds, Their method of preparation and pharmaceutical compositions in which they are present
11/11/1997US5686496 Aromatic ether amidine used for treating diseases involve inflammatory and/or allergic processes
11/11/1997US5686485 Physiologically active EI-1941 compounds
11/11/1997US5686480 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
11/11/1997US5686478 Endothelin antagonists
11/11/1997US5686477 5-(arloxymethyl)oxazolines
11/11/1997US5686467 2-phenyl-3-aroylbenzothiophenes
11/11/1997US5686462 Anti-inflammatory method
11/11/1997US5686459 Anticoagulants
11/11/1997US5686455 Imidazole derivatives and their use as cytokine inhibitors
11/11/1997US5686454 Preventing labor, vasodilation, diuresis, hypotensive agents, anticoagulants, treating dysmenorrhea
11/11/1997US5686451 Combination of an ace inhibitor and a diuretic
11/11/1997US5686431 Methods of using low molecular weight heparins for treatment of pathological processes
11/11/1997US5686426 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
11/11/1997US5686409 Administering serine protease inhibitor
11/11/1997US5685195 Crank assembly for a screen wiper drive of an automotive vehicle
11/06/1997WO1997041227A1 Plasmid-based vaccine for treating atherosclerosis
11/06/1997WO1997041147A1 Novel compounds
11/06/1997WO1997041127A1 Halo-substituted protein kinase c inhibitors
11/06/1997WO1997041125A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
11/06/1997WO1997041121A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them